Patents by Inventor Susan V. Lynch

Susan V. Lynch has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MICROBIAL CONSORTIA
    Publication number: 20220378850
    Abstract: Provided herein are microbial strains isolated de novo. In some instances, the bacterial strains include genera, species, and/or strains of Lactobacillus johnsonii, Lactobacillus crispatus, Faecalibacterium prausnitzii, Akkermansia muciniphila, Bifidobacterium longum, and/or Bifidobacterium longum infantis strains. These bacterial strains can be used in the treatment of dysbiosis, inflammation, and other disorders.
    Type: Application
    Filed: April 22, 2022
    Publication date: December 1, 2022
    Inventors: Nikole KIMES, Ricardo Valladares, Benjamin Fiebiger, Susan V. Lynch
  • Microbial consortia
    Patent number: 11369644
    Abstract: Provided herein are microbial strains isolated de novo. In some instances, the bacterial strains include genera, species, and/or strains of Lactobacillus johnsonii, Lactobacillus crispatus, Faecalibacterium prausnitzii, Akkermansia muciniphila, Bifidobacterium longum, and/or Bifidobacterium longum infantis strains. These bacterial strains can be used in the treatment of dysbiosis, inflammation, and other disorders.
    Type: Grant
    Filed: October 9, 2020
    Date of Patent: June 28, 2022
    Assignees: SIOLTA THERAPEUTICS, INC., THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
    Inventors: Nikole Kimes, Ricardo Valladares, Benjamin Fiebiger, Susan V. Lynch
  • METHODS AND COMPOSITIONS FOR TREATING AND PREVENTING INFLAMMATORY DISEASES
    Publication number: 20220047653
    Abstract: Provided herein are, inter alia, methods and compositions for treating, preventing, or reducing the risk of dysbiosis, inflammation, inflammatory diseases, childhood obesity, and premature birth. Included are methods and compositions for increasing or promoting healthy or normal immune system maturation. In aspects, provided herein are methods and compositions for detecting and isolating bacterial strains. Isolated bacterial strains and culture methods are also provided.
    Type: Application
    Filed: August 6, 2019
    Publication date: February 17, 2022
    Inventors: Susan V. LYNCH, Elze RACKAITYTE
  • MICROBIAL CONSORTIA
    Publication number: 20210077541
    Abstract: Provided herein are microbial strains isolated de novo. In some instances, the bacterial strains include genera, species, and/or strains of Lactobacillus johnsonii, Lactobacillus crispatus, Faecalibacterium prausnitzii, Akkermansia muciniphila, Bifidobacterium longum, and/or Bifidobacterium longum infantis strains. These bacterial strains can be used in the treatment of dysbiosis, inflammation, and other disorders.
    Type: Application
    Filed: October 9, 2020
    Publication date: March 18, 2021
    Inventors: Nikole KIMES, Ricardo VALLADARES, Benjamin FIEBIGER, Susan V. LYNCH
  • METHODS AND COMPOSITIONS RELATING TO EPOXIDE HYDROLASE GENES
    Publication number: 20200407796
    Abstract: Provided herein are, inter alia, methods and kits for detecting epoxide hydrolase genes. In embodiments, methods and kits for detecting the risk of developing atopy or asthma are included. Also included are methods for preventing or treating atopy or asthma.
    Type: Application
    Filed: March 1, 2019
    Publication date: December 31, 2020
    Inventors: Susan V. LYNCH, Sophia Rose LEVAN
  • Nitroreductase enzymes
    Patent number: 7687474
    Abstract: Compositions and methods are provided for the treatment of cancer.
    Type: Grant
    Filed: December 20, 2006
    Date of Patent: March 30, 2010
    Assignee: The Board of Trustees of the Leland Stanford Junior University
    Inventors: A. C. Matin, Yoram Barak, Susan V. Lynch, David F. Ackerley, Stephen H. Thorne, Christopher H. Contag, Jianghong Rao